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Abstract
Red blood cells (RBCs) have various roles that are important in making sure that the body 
functions properly. They are responsible for delivering oxygen and removing carbon dioxide and 
other waste gases to and from the body. Studies have shown that storing blood for extended 
amounts of time leads to more oxygen entering the blood, causing oxidative stress and also 
formation of microparticles. Small in size (<1 micron), microparticles are membrane vesicles 
that are released by RBCs and other types of cells such as platelets, leukocytes, and 
endothelial cells. It has been shown that microparticles are increased in the plasma of patients 
with cardiovascular disease, however conflicting evidence has lead to the idea that the 
increased release of microparticles may be harmful to patient care. Other research findings 
suggest that microparticles derived from RBCs are actually protective against pro-inflammatory 
signals in endothelial cells. The aim of this project was to test the hypothesis that microparticles 
from younger red blood cells protect against oxidative stress signals in human endothelial cells, 
and as they age, if they enhance the oxidative stress response.  
The primary research methods used for this study were the staining of RBC membranes with 
antibodies and analysis with a flow cytometer, measuring reactive oxygen species production 
through reactive oxygen species (ROS) assays, and observing the structural changes of the red 
blood cells using bright field microscopy. Results suggested that there was only an observed 
increase in the microparticle events among the RBC samples that contained only calcium 
ionophore. The other data for the RBC samples do not seem to support the initial hypothesis 
that was made. Further research needs to be completed to prove whether microparticles 
contain protective properties or if they contribute to cardiovascular diseases. 
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Introduction
Coronary Heart Disease (CHD) is the most common form of cardiovascular disease. CHD occurs 
when the arteries supplying blood to the heart become narrow and stiffen due to the build up of plaque 
[1]. The formation of plaque is also known as atherosclerosis, a chronic inflammatory condition, 
characterized by monocyte recruitment to the wall of the large arteries, endothelial dysfunction, and 
oxidative stress, and secretion of pro-inflammatory mediators.
Red blood cells (RBCs) have various roles that are important in making sure that the body functions 
properly. They are responsible for delivering oxygen and removing carbon dioxide and other waste 
gases to and from the body.  Red blood cells obtain their bright red color from the protein hemoglobin, 
which contains iron and helps transport oxygen and carbon dioxide with ease. As blood passes 
through the lungs, oxygen molecules attach to the hemoglobin. Then, as blood moves through the 
body’s tissues, the hemoglobin frees the oxygen to the cells. Carbon dioxide then attaches to the 
hemoglobin, which transports the CO2 away [2]. 
Research has shown that storing blood for extended amounts of time leads to more oxygen entering 
the blood, causing oxidative stress, and also formation of microparticles. Microparticles are membrane 
vesicles that are released by RBCs and other types of cells such as platelets, leukocytes, and 
endothelial cells. They are 1mm in diameter and possess pro-inflammatory and pro-coagulant 
properties [3]. Their formation is due to a calcium influx that is frequently caused by apoptosis and cell 
activation [4]. Although this is a normal process that happens in the body frequently, the formation of 
microparticles is believed to increase over time in stored blood. 
While some research studies have suggested that there is an increase in microparticle formation in the 
plasma of patients with cardiovascular diseases, others have suggested that microparticles formed 
from RBCs actually protect against pro-inflammatory sign in human endothelial cells. Endothelial cells 
form the inner lining of a blood vessel and provide an anticoagulant barrier between the vessel wall 
and the blood. However, conflicting evidence shows that RBC-derived microparticles have a key role 
in the processes of inflammation, coagulation, and vascular function, which are all involved in the 
pathogenesis of cardiovascular diseases [4], [5]. The primary aim of this project was to test the 
hypothesis that microparticles from younger red blood cells protect against oxidative stress signals in 
human endothelial cells, and as they age, whether they enhance the oxidative stress response. This 
study consisted of using a cocktail of different inhibitors in order to observe the effect it had on the 






Figure 2: Comparison graph of Day 2 and Day 
6 microparticle formation for Sample 2
Figure 1: Comparison graph of Day 2 and Day 6 
microparticle formation for Sample 1
Figure 3: Comparison of Day 2 and Day 27
RBC samples from microscope.
Materials:
Two blood packs with different blood types were collected and rationed into four 50 mL test tubes for 
the purpose of this study. 1x phosphate buffered saline solution was used to dilute the blood samples 
and other used as a solvent for other solutions. 
The following inhibitors were used to test the activity of microparticles: 1µM calcium ionophore, 2.5µM 
calcium chloride solution, 1µM mitogen-activated protein kinase (MEK) inhibitor (U0126), and 1µM 
calpain inhibitor. 
1x Annexin buffer, sizing beads, enumeration beads were used to prepare the control tubes, as well as 
the samples. The controls and samples were placed in FACS tubes to be analyzed by the flow 
cytometer. The antibodies anti-CD235 (gylcophorin A), anti-CD61 (intergrin b3/glycoprotein llla) and 
annexin V-Cy7 were added to the RBC supernatants for preparation for microparticle analysis with the 
flow cytometer. 
For preparation of the ROS assays, white opaque 96 well plates were plated with human umbilical vein 
endothelial cells (HUVEC), then later was incubated with 100 µM DHR, M199/10% FCS, and 20 µM 
hydrogen peroxide solution. 
Methods:
1. Isolation of Red Blood Cells from Whole Blood Research Blood Pack 
2. Staining of Scrambled RBC Membranes with Antibodies, Annexin V-Cy7, and Merocyanine (MC540)






























































The findings suggest that the calcium ionophore treated RBC sample showed an 
increase in microparticle formation and that the other samples did not reflect a 
significant increase in microparticle formation. The microparticles in the samples that 
did not include calcium ionophore showed relatively the same amount of 
microparticles from the first day (Day 1) to the last day (Day 27). Since it was known 
that there would be an increase in microparticle formation with the inhibition of Erk
activity and the treatment of calcium ionophore, it was quite simple to see if the 
correlations do hold true over time. It was a similar case with the addition of the 
calpain inhibitor except it is expected that there will be a decrease in microparticle 
formation. From the observed data, it suggested that there was only an observed 
increase in the microparticle events among the RBC samples that contained only 
calcium ionophore. 
The other data for the RBC samples do not seem to align with the initial hypothesis 
made by other research. There was also evidence in the cellular structure of the RBC 
samples that much change did not occur in regards to microparticle formation. The 
major difference between the samples from day 2 and day 27 is that the day 27 
RBCs samples seemed to have lysed and there is no particular shape, where as the 
day 2 RBCs samples seem to have a distinct shape. 
In this study, multiple research methods were utilized and data was generated. 
However, there were multiple factors that contributed to some of the 
inaccuracies of the study. For example, the ROS assays did not prove to be a 
successful procedure because of some procedural errors that occurred. 
For future projects pertaining to this research study, a ROS assay needs to be 
completed to test the initial hypothesis regarding if microparticle exists as 
reactive oxygen species. This would then address the issues on if 
microparticles are a result of cardiovascular disease and if they do have pro-
inflammatory properties that prevent oxidative stress.   
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